Semaglutide and Male Fertility: What the Research Shows

    By Trimi Medical Team10 min read

    For men who are trying to conceive or plan to in the future, the question of how semaglutide might affect fertility is an important one. While much of the reproductive safety discussion around GLP-1 medications has focused on women, male fertility deserves equal attention. Here's what the current evidence tells us.

    Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. If you have concerns about fertility, consult a reproductive endocrinologist or urologist.

    Obesity and Male Fertility: The Background

    Before examining semaglutide's specific effects, it's essential to understand how obesity itself impacts male fertility. Excess weight is one of the most significant modifiable risk factors for male infertility:

    Hormonal Disruption

    Obesity causes a well-documented cascade of hormonal changes that impair male reproductive function:

    • Reduced testosterone: Excess fat tissue converts testosterone to estradiol through aromatization, lowering total and free testosterone levels. Men with BMI over 30 have approximately 25–45% lower testosterone than normal-weight men.
    • Elevated estrogen: Higher estradiol levels suppress the hypothalamic-pituitary-gonadal (HPG) axis, reducing the hormonal signals (FSH and LH) that drive sperm production.
    • Insulin resistance: Impairs Leydig cell function (testosterone-producing cells in the testes) and affects Sertoli cell function (cells that support sperm development).
    • Elevated leptin: High leptin levels in obesity can directly inhibit testosterone production.

    Sperm Quality Impact

    Multiple studies and meta-analyses have demonstrated that obesity is associated with:

    • Reduced sperm count (oligozoospermia)
    • Decreased sperm motility (asthenozoospermia)
    • Increased sperm DNA fragmentation
    • Abnormal sperm morphology (teratozoospermia)
    • Reduced semen volume
    • Increased oxidative stress in seminal fluid

    Physical Factors

    Excess abdominal and scrotal fat increases testicular temperature, which is detrimental to sperm production. The testes need to be 2–4 degrees cooler than core body temperature for optimal spermatogenesis, and excess fat insulation can compromise this temperature regulation.

    What Does Semaglutide Do to Male Fertility?

    The direct effects of semaglutide on male fertility have not been extensively studied in humans. However, available evidence comes from several sources.

    Animal Studies

    Animal reproductive toxicity studies conducted during semaglutide's development provide some data:

    • In male rats, semaglutide at clinically relevant doses did not significantly affect fertility or early embryonic development.
    • At higher doses (exceeding human therapeutic doses), some studies reported minor effects on testicular weight and sperm parameters in rodent models.
    • These animal findings should be interpreted cautiously, as rodent reproductive biology differs significantly from human reproductive biology.

    Human Data

    No large-scale clinical trials have specifically studied semaglutide's effects on male fertility parameters (semen analysis, sperm quality, time to conception). The FDA prescribing information does not cite specific fertility warnings for men, unlike the guidance for women regarding pregnancy.

    However, indirect evidence from the clinical trial program and observational data suggests that the net effect of semaglutide use on male fertility is likely positive, driven primarily by the beneficial effects of weight loss. Learn more about GLP-1 mechanisms on our how it works page.

    How Weight Loss on Semaglutide May Improve Male Fertility

    The weight loss achieved with semaglutide can reverse many of the obesity-related fertility impairments:

    Testosterone Recovery

    As visceral fat decreases, aromatization drops and testosterone levels typically rise. Studies show that men who lose 10% or more of body weight can see testosterone increases of 50–100+ ng/dL. This hormonal improvement supports both libido and spermatogenesis.

    Improved HPG Axis Function

    With reduced estradiol and improved insulin sensitivity, the HPG axis can function more normally, restoring appropriate levels of FSH and LH — the hormones that directly stimulate sperm production and maturation.

    Reduced Oxidative Stress

    Weight loss and improved metabolic health reduce systemic oxidative stress, which is a major contributor to sperm DNA damage. GLP-1 medications have also demonstrated antioxidant properties in some studies, though this effect has not been specifically studied in relation to semen quality.

    Improved Testicular Temperature

    Reduced abdominal and scrotal fat improves testicular thermoregulation, potentially enhancing spermatogenesis.

    Better Erectile Function

    Improved erectile function resulting from weight loss and testosterone recovery directly supports fertility by enabling natural conception. Read more about GLP-1 and erectile dysfunction.

    Potential Concerns

    While the overall picture is encouraging, several theoretical concerns deserve attention:

    Caloric Restriction and Sperm Production

    Severe caloric restriction can impair spermatogenesis. The significant appetite suppression from semaglutide could potentially lead to caloric intake low enough to affect sperm production, particularly during the dose-escalation phase. Men trying to conceive should ensure adequate caloric intake — a moderate deficit for weight loss, not starvation-level restriction.

    Nutritional Deficiencies

    Reduced food intake on semaglutide can lead to deficiencies in nutrients important for sperm production, including zinc, selenium, folate, vitamin D, and omega-3 fatty acids. Supplementation or careful dietary planning is advisable for men concerned about fertility.

    Rapid Hormonal Changes

    Rapid weight loss can cause short-term hormonal fluctuations as the body adjusts. Sperm production takes approximately 72 days (the spermatogenic cycle), so any hormonal disruptions during rapid weight loss could theoretically affect sperm quality 2–3 months later. This effect, if it occurs, would be temporary.

    Unknown Direct Effects

    GLP-1 receptors have been identified in the testes and other reproductive tissues in animal studies. Whether semaglutide directly affects these receptors in human reproductive tissue is unknown. The theoretical concern exists but is unsupported by clinical evidence.

    Practical Recommendations for Men Trying to Conceive

    If you are planning to start a family and considering or currently using semaglutide, consider the following guidance:

    • Discuss with your provider: Let your prescribing provider know about your fertility plans. Unlike with women, there is no recommendation to stop semaglutide before attempting conception in men.
    • Consider a semen analysis: A baseline semen analysis before starting semaglutide and a follow-up at 3–6 months can help track any changes.
    • Maintain adequate nutrition: Don't let semaglutide's appetite suppression lead to extreme caloric restriction. Aim for a moderate deficit of 500–750 calories below maintenance.
    • Supplement wisely: Consider a men's fertility supplement containing zinc (30 mg), selenium (200 mcg), folate (400 mcg), vitamin C (1,000 mg), vitamin E (400 IU), and CoQ10 (200 mg).
    • Avoid excessive heat: Hot tubs, saunas, and tight underwear can impair sperm production — relevant advice regardless of medication status.
    • Limit alcohol: Take advantage of semaglutide's natural alcohol-reducing effect. Excessive alcohol independently harms sperm quality.
    • Exercise moderately: Regular exercise supports testosterone and fertility, but extreme endurance training can have the opposite effect.

    Visit our treatments page for more information about starting GLP-1 therapy.

    Semaglutide vs. Other Fertility Concerns

    To put semaglutide's potential fertility effects in context, consider that the following common factors have well-documented negative effects on male fertility:

    • Obesity itself: Causes significantly more reproductive harm than any theoretical effect of semaglutide
    • Testosterone replacement therapy: Directly suppresses sperm production (often to near zero) — a much greater fertility risk than semaglutide
    • Anabolic steroids: Severely impair spermatogenesis
    • Heavy alcohol use: Directly toxic to testicular tissue
    • Smoking: Reduces sperm count, motility, and morphology
    • Chronic stress: Suppresses the HPG axis and testosterone production

    Compared to these well-established fertility threats, semaglutide's theoretical risks are minimal, and its indirect benefits through weight loss are substantial.

    Frequently Asked Questions

    Should I stop semaglutide if we're trying to get pregnant?

    Unlike the recommendation for women (who should stop semaglutide at least two months before conception), there is no current recommendation for men to stop semaglutide when trying to conceive. The weight loss benefits likely outweigh any theoretical risks to sperm quality. Discuss your specific situation with your provider.

    Can semaglutide cause infertility in men?

    There is no evidence that semaglutide causes male infertility. On the contrary, the weight loss and metabolic improvements it produces may actually improve fertility in overweight and obese men by restoring testosterone levels and improving sperm quality.

    Will semaglutide affect my sperm count?

    Direct effects of semaglutide on sperm count have not been studied in humans. However, the weight loss and hormonal improvements associated with semaglutide use are generally expected to improve sperm parameters in men whose fertility is compromised by obesity.

    How long does it take for sperm quality to improve after weight loss?

    Spermatogenesis (the production of new sperm) takes approximately 72 days. Any improvements in hormonal and metabolic status from weight loss would be reflected in sperm quality approximately 2–3 months later. Full improvement may take 6–12 months of sustained weight management.

    I'm on both semaglutide and TRT. Should I be concerned about fertility?

    Yes, but the concern is the TRT, not the semaglutide. Testosterone replacement therapy suppresses natural testosterone and sperm production. If fertility is desired, discuss alternatives to TRT (such as clomiphene citrate or hCG) with your urologist. Weight loss on semaglutide may reduce or eliminate the need for TRT by naturally restoring testosterone levels.

    The Bottom Line

    Based on current evidence, semaglutide is unlikely to harm male fertility and may significantly improve it by addressing obesity — one of the most impactful modifiable risk factors for male infertility. The weight loss, hormonal improvements, and metabolic benefits of GLP-1 therapy create a more favorable environment for sperm production and quality.

    Men who are concerned about fertility should maintain adequate nutrition, consider fertility-supporting supplements, and discuss their reproductive goals with their healthcare provider. If you're ready to explore GLP-1 therapy, visit Trimi's treatments page to get started.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading